{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Adenocarcinoma+of+the+Pancreas&page=21", "query": { "condition": "Adenocarcinoma of the Pancreas", "page": 21 }, "page_size": 10 }, "pagination": { "page": 21, "page_size": 10, "total_count": 929, "total_pages": 93, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Adenocarcinoma+of+the+Pancreas&page=22&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Adenocarcinoma+of+the+Pancreas&page=20&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-15T11:52:44.321Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05374876", "title": "Hand Therapy Intervention Versus Traditional Occupational Therapy to Prevent Chemotherapy Induced Peripheral Neuropathy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Adenocarcinoma of Pancreas" ], "interventions": [ { "name": "Hand Therapy Until CIPN", "type": "OTHER" }, { "name": "Traditional Occupational Therapy (TOT)", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "HonorHealth Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 49, "start_date": "2016-05-13", "completion_date": "2021-09-30", "has_results": true, "last_update_posted_date": "2026-07-08", "last_synced_at": "2026-10-15T11:52:44.321Z", "location_count": 1, "location_summary": "Scottsdale, Arizona", "locations": [ { "city": "Scottsdale", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT05374876" }, { "nct_id": "NCT04682431", "title": "A Phase 1a/1b FIH Study of PY159 and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Advanced Solid Tumor", "Gynecologic Cancer", "Breast Cancer", "Colorectal Cancer", "Gastric Adenocarcinoma", "Lung Adenocarcinoma", "Pancreatic Cancer", "Head and Neck Cancer" ], "interventions": [ { "name": "PY159 Single agent dose level 1", "type": "DRUG" }, { "name": "PY159 Single agent dose level 2", "type": "DRUG" }, { "name": "PY159 Single agent dose level 3", "type": "DRUG" }, { "name": "PY159 Single agent dose level 4", "type": "DRUG" }, { "name": "PY159 Single agent dose level 5", "type": "DRUG" }, { "name": "PY159 Single agent dose level 6", "type": "DRUG" }, { "name": "PY159 Single agent dose level 7", "type": "DRUG" }, { "name": "PY159/Pembrolizumab Combination dose level 1", "type": "DRUG" }, { "name": "PY159/Pembrolizumab Combination dose level 2", "type": "DRUG" }, { "name": "PY159/Pembrolizumab Combination dose level 3", "type": "DRUG" }, { "name": "PY159/Pembrolizumab Combination dose level 4", "type": "DRUG" }, { "name": "PY159 Single agent dose expansion cohort", "type": "DRUG" }, { "name": "PY159/Pembrolizumab Combination dose expansion cohort 1", "type": "DRUG" }, { "name": "PY159/Pembrolizumab Combination dose expansion cohort 2", "type": "DRUG" }, { "name": "PY159/Pembrolizumab Combination dose expansion cohort 3", "type": "DRUG" }, { "name": "PY159/Pembrolizumab Combination dose expansion cohort 4", "type": "DRUG" }, { "name": "PY159/Pembrolizumab Combination dose expansion cohort 5", "type": "DRUG" }, { "name": "PY159/Pembrolizumab Combination dose expansion cohort 6", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Ikena Oncology", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 127, "start_date": "2020-11-10", "completion_date": "2023-08-31", "has_results": false, "last_update_posted_date": "2024-03-22", "last_synced_at": "2026-10-15T11:52:44.321Z", "location_count": 17, "location_summary": "Los Angeles, California • San Francisco, California • Santa Monica, California + 14 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Santa Monica", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT04682431" }, { "nct_id": "NCT05651022", "title": "Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Solid Tumor, Adult", "HCC - Hepatocellular Carcinoma", "CRC (Colorectal Cancer)", "Pancreatic Adenocarcinoma", "NSCLC Non-small Cell Lung Cancer", "Squamous Cell Cancer of the Head and Neck", "UC (Urothelial Cancer)", "MSI-H Cancer" ], "interventions": [ { "name": "Decoy20", "type": "DRUG" }, { "name": "Tislelizumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Indaptus Therapeutics, Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 120, "start_date": "2023-02-28", "completion_date": "2027-09-30", "has_results": false, "last_update_posted_date": "2026-01-13", "last_synced_at": "2026-10-15T11:52:44.321Z", "location_count": 12, "location_summary": "Los Angeles, California • Newport Beach, California • Atlanta, Georgia + 8 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Newport Beach", "state": "California" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Detroit", "state": "Michigan" }, { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT05651022" }, { "nct_id": "NCT07253662", "title": "Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Patients With Peritoneal Metastasis From Pancreatic Adenocarcinoma", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Adenocarcinoma Pancreas" ], "interventions": [ { "name": "PIPAC", "type": "DEVICE" }, { "name": "Nab-paclitaxel", "type": "DRUG" } ], "intervention_types": [ "DEVICE", "DRUG" ], "sponsor": "Northwell Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 10, "start_date": "2026-01-11", "completion_date": "2027-12-30", "has_results": false, "last_update_posted_date": "2026-06-03", "last_synced_at": "2026-10-15T11:52:44.321Z", "location_count": 1, "location_summary": "New Hyde Park, New York", "locations": [ { "city": "New Hyde Park", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT07253662" }, { "nct_id": "NCT03250273", "title": "A Clinical Trial of Entinostat in Combination With Nivolumab for Patients With Previously Treated Unresectable or Metastatic Cholangiocarcinoma and Pancreatic Adenocarcinoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Metastatic Cholangiocarcinoma", "Cholangiocarcinoma", "Pancreatic Cancer", "Metastatic Pancreatic Cancer", "Unresectable Pancreatic Cancer", "Unresectable Cholangiocarcinoma" ], "interventions": [ { "name": "Entinostat", "type": "DRUG" }, { "name": "Nivolumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 44, "start_date": "2017-11-06", "completion_date": "2020-11-20", "has_results": true, "last_update_posted_date": "2025-05-28", "last_synced_at": "2026-10-15T11:52:44.321Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT03250273" }, { "nct_id": "NCT07124611", "title": "A Brief Psychological Intervention to Improve Emotional Well-Being During Neoadjuvant Therapy for Pancreatic Cancer", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Localized Pancreatic Ductal Adenocarcinoma", "Stage 0 Pancreatic Cancer AJCC v8", "Stage I Pancreatic Cancer AJCC v8", "Stage IIA Pancreatic Cancer AJCC v8" ], "interventions": [ { "name": "Interview", "type": "OTHER" }, { "name": "Nutritional Therapy", "type": "PROCEDURE" }, { "name": "Physical Therapy", "type": "PROCEDURE" }, { "name": "Psychosocial Care", "type": "BEHAVIORAL" }, { "name": "Questionnaire Administration", "type": "OTHER" } ], "intervention_types": [ "OTHER", "PROCEDURE", "BEHAVIORAL" ], "sponsor": "Ohio State University Comprehensive Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 60, "start_date": "2025-12-22", "completion_date": "2026-12-31", "has_results": false, "last_update_posted_date": "2026-02-19", "last_synced_at": "2026-10-15T11:52:44.321Z", "location_count": 1, "location_summary": "Columbus, Ohio", "locations": [ { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT07124611" }, { "nct_id": "NCT04484909", "title": "NBTXR3 Activated by Radiation Therapy for the Treatment of Locally Advanced or Borderline-Resectable Pancreatic Cancer", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Borderline Resectable Pancreatic Adenocarcinoma", "Locally Advanced Pancreatic Ductal Adenocarcinoma", "Resectable Pancreatic Ductal Adenocarcinoma", "Stage III Pancreatic Cancer AJCC v8" ], "interventions": [ { "name": "Hafnium Oxide-containing Nanoparticles NBTXR3", "type": "OTHER" }, { "name": "Radiation Therapy", "type": "RADIATION" } ], "intervention_types": [ "OTHER", "RADIATION" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 24, "start_date": "2020-07-01", "completion_date": "2026-12-31", "has_results": false, "last_update_posted_date": "2026-05-22", "last_synced_at": "2026-10-15T11:52:44.321Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04484909" }, { "nct_id": "NCT06947395", "title": "Clinical Validation of a Blood Biomarker Test to Detect Early-Stage Pancreatic Cancer (VERIFI)", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Cancer of the Pancreas", "Pancreatic Cancer", "Pancreas Neoplasms", "Pancreatic Carcinoma Stage I", "Pancreatic Carcinoma Stage II" ], "interventions": [ { "name": "PancreaSure", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Immunovia, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "45 Years", "maximum_age": null, "sex": "ALL", "summary": "45 Years and older" }, "enrollment_count": 386, "start_date": "2025-02-11", "completion_date": "2025-04-07", "has_results": false, "last_update_posted_date": "2025-04-27", "last_synced_at": "2026-10-15T11:52:44.321Z", "location_count": 6, "location_summary": "Scottsdale, Arizona • New York, New York • Pittsburgh, Pennsylvania + 3 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "New York", "state": "New York" }, { "city": "Pittsburgh", "state": "Pennsylvania" }, { "city": "Memphis", "state": "Tennessee" }, { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06947395" }, { "nct_id": "NCT00538850", "title": "Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Cancer" ], "interventions": [ { "name": "Fentanyl sublingual spray", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "INSYS Therapeutics Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 130, "start_date": "2007-10", "completion_date": "2010-10", "has_results": true, "last_update_posted_date": "2014-03-05", "last_synced_at": "2026-10-15T11:52:44.321Z", "location_count": 1, "location_summary": "Chandler, Arizona", "locations": [ { "city": "Chandler", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00538850" }, { "nct_id": "NCT03331562", "title": "A SU2C Catalyst® Trial of a PD1 Inhibitor With or Without a Vitamin D Analog for the Maintenance of Pancreatic Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Pancreatic Cancer", "Pancreas Adenocarcinoma", "Advanced Pancreatic Cancer", "Metastatic Pancreatic Cancer", "Metastatic Pancreatic Adenocarcinoma" ], "interventions": [ { "name": "Pembrolizumab", "type": "DRUG" }, { "name": "paricalcitol", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Translational Genomics Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 24, "start_date": "2017-12-27", "completion_date": "2020-07-10", "has_results": true, "last_update_posted_date": "2022-12-27", "last_synced_at": "2026-10-15T11:52:44.321Z", "location_count": 6, "location_summary": "Scottsdale, Arizona • Duarte, California • Westwood, Kansas + 3 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Duarte", "state": "California" }, { "city": "Westwood", "state": "Kansas" }, { "city": "Morristown", "state": "New Jersey" }, { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03331562" } ] }